Drug Discovery Market 2026 highlighting strong innovation-driven opportunities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Drug Discovery Market Between 2026 And 2030?

The drug discovery market has seen significant expansion in recent years. This market is expected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be attributed to an uptick in chronic and infectious diseases, advancements in molecular biology techniques, increased research and development spending by pharmaceutical companies, a rise in biotechnology collaborations, and the accessibility of research funding.

The drug discovery market is projected to experience substantial growth in the upcoming years. This market is forecast to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This expansion over the forecast period is driven by factors such as the rise of AI-powered drug discovery platforms, the increasing scope of personalized medicine, the incorporation of omics data into drug design, the growth in biopharmaceutical outsourcing, and the widespread use of automation and robotics within laboratory settings. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the evolution of targeted drug development, refined personalized medicine approaches, the integration of pharmacogenomics, and nanotechnology-enabled drug discovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Key Drivers Are Influencing The Growth Of The Drug Discovery Market?

The future expansion of the drug discovery market is anticipated to be fueled by increasing healthcare spending. Globally, nations allocate a significant portion of their Gross Domestic Product to various healthcare costs, encompassing hospital services, doctor and clinical visits, other specialized services, dental treatments, additional health, residential, and personal care, at-home health assistance, long-term nursing facilities, continuing care retirement communities, prescription medications, among other expenditures. Drug discovery constitutes a substantial component of health expenditure because it is essential for disease treatment and life extension. The demand for novel drugs to combat emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure expanded by 4.1% to reach $4.5 trillion in 2022, amounting to $13,493 per person. Furthermore, from 2023–32, the average national health expenditure growth (5.6%) is forecasted to exceed the average GDP growth (4.3%), leading to an increase in health spending’s share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the escalation in healthcare spending is driving the expansion of the drug discovery market.

Which Market Segments Are Examined In The Drug Discovery Market Study?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Trends Are Influencing The Drug Discovery Market?

Leading companies in the drug discovery market are developing various new technologies, such as AI, imaging technology, and others, to decrease the time required for drug discovery. Imaging technology allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which utilize the strengths of either probes or the tissue itself, are essential for understanding diseases and discovering new treatments. For instance, in May 2023, Google Cloud recently introduced two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, aimed at accelerating drug discovery and precision medicine. These tools are built to help biotech and pharmaceutical companies advance drug discovery and precision medicine. The Target and Lead Identification Suite supports the identification of amino acid and protein functions, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, assisting in the design of precision treatments.

Who Are The Primary Competitors In The Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Read the full drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795